A role for naturally occurring alleles of Endoplasmic Reticulum Aminopeptidases in tumor immunity and cancer predisposition

Frontiers in Oncology

Volumn 4, Issue NOV, 2014, Pages

  Stratikos, Efstratios ^a   Stamogiannos, Athanasios ^a   Zervoudi, Efthalia ^a   Fruci, Doriana ^b  

^a INSTITUTE OF NANOSCIENCE AND NANOTECHNOLOGY   (Greece)

^b BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOPEPTIDASE; AMINOPEPTIDASE 2; AMINOPEPTIDASE I; CD4 ANTIGEN; CD8 ANTIGEN; CRYOPYRIN; EPITOPE; GAMMA INTERFERON; HLA ANTIGEN; INTERLEUKIN 6; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MESSENGER RNA; PROTEASOME; TUMOR NECROSIS FACTOR RECEPTOR; UBIQUITIN; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; ALLELE; ANTIGEN PRESENTATION; ARTICLE; CANCER IMMUNOTHERAPY; CANCER SUSCEPTIBILITY; CYTOTOXIC T LYMPHOCYTE; DISEASE ASSOCIATION; ENDOPLASMIC RETICULUM; ENZYME ACTIVITY; ENZYME POLYMORPHISM; GENETIC PREDISPOSITION; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; INNATE IMMUNITY; LYMPH NODE METASTASIS; MAJOR HISTOCOMPATIBILITY COMPLEX; NATURAL KILLER CELL; NONHUMAN; PROTEIN EXPRESSION; RISK; SINGLE NUCLEOTIDE POLYMORPHISM; SURVIVAL; TUMOR ESCAPE; TUMOR GROWTH; TUMOR IMMUNITY; TUMOR MICROENVIRONMENT; VIRUS INFECTION;

EID: 84915811256     PISSN: None     EISSN: 2234943X     Source Type: Journal    
DOI: 10.3389/fonc.2014.00363     Document Type: Article

References (77)

1. Aldhamen, Y.A., Seregin, S.S., Rastall, D.P., Aylsworth, C.F., Pepelyayeva, Y., Busuito, C.J., Amalfitano, A. (2013). Endoplasmic reticulum aminopeptidase-1 functions regulate key aspects of the innate immune response. PLoS One 8, e69539. doi: 10.1371/journal.pone.0069539.
2. Andres, A.M., Dennis, M.Y., Kretzschmar, W.W., Cannons, J.L., Lee-Lin, S.Q., Hurle, B., Green, E.D. (2010). Balancing selection maintains a form of ERAP2 that undergoes nonsense-mediated decay and affects antigen presentation. PLoS Genet 6, e1001157. doi: 10.1371/journal.pgen.1001157.
3. Birtley, J.R., Saridakis, E., Stratikos, E., and Mavridis, I.M. (2012). The Crystal Structure of Human Endoplasmic Reticulum Aminopeptidase 2 Reveals the Atomic Basis for Distinct Roles in Antigen Processing. Biochemistry 51, 286-295.
4. Burton, P.R., Clayton, D.G., Cardon, L.R., Craddock, N., Deloukas, P., Duncanson, A., Brown, M. (2007). Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants. Nat Genet 39,1329-1337. doi: ng.2007.17 [pii] 10.1038/ng.2007.17.
5. Cagliani, R., Riva, S., Biasin, M., Fumagalli, M., Pozzoli, U., Lo Caputo, S., Sironi, M. (2010). Genetic diversity at endoplasmic reticulum aminopeptidases is maintained by balancing selection and is associated with natural resistance to HIV-1 infection. Hum Mol Genet 19, 4705-4714. doi: ddq401 [pii] 10.1093/hmg/ddq401.
6. Cascio, P., Hilton, C., Kisselev, A.F., Rock, K.L., and Goldberg, A.L. (2001). 26S proteasomes and immunoproteasomes produce mainly N-extended versions of an antigenic peptide. EmboJ 20, 2357-2366.
7. Chen, L., Fischer, R., Peng, Y., Reeves, E., Mchugh, K., Ternette, N., Bowness, P. (2014). Critical Role of Endoplasmic Reticulum Aminopeptidase 1 in Determining the Length and Sequence of Peptides Bound and Presented by HLA-B27. Arthritis Rheumatol 66, 284-294. doi: 10.1002/art.38249.
8. Cifaldi, L., Lo Monaco, E., Forloni, M., Giorda, E., Lorenzi, S., Petrini, S., Fruci, D. (2011). Natural killer cells efficiently reject lymphoma silenced for the endoplasmic reticulum aminopeptidase associated with antigen processing. Cancer Res 71,1597-1606. doi: 10.1158/0008-5472.CAN-10-3326.
9. Colonna, M., and Samaridis, J. (1995). Cloning of immunoglobulin-superfamily members associated with HLA-C and HLA-B recognition by human natural killer cells. Science 268, 405-408.
10. Crotty, S. (2011). Follicular helper CD4 T cells (TFH). Annu Rev Immunol 29, 621-663. doi: 10.1146/annurev-immunol-031210-101400.
11. Cui, X., Hawari, F., Alsaaty, S., Lawrence, M., Combs, C.A., Geng, W., Levine, S.J. (2002). Identification of ARTS-1 as a novel TNFR1-binding protein that promotes TNFR1 ectodomain shedding. J Clin Invest 110, 515-526. doi: 10.1172/JCI13847.
12. Cui, X., Rouhani, F.N., Hawari, F., and Levine, S.J. (2003a). An aminopeptidase, ARTS-1, is required for interleukin-6 receptor shedding. J Biol Chem 278, 28677-28685. doi: 10.1074/jbc. M300456200.
13. Cui, X., Rouhani, F.N., Hawari, F., and Levine, S.J. (2003b). Shedding of the type II IL-1 decoy receptor requires a multifunctional aminopeptidase, aminopeptidase regulator of TNF receptor type 1 shedding. J Immunol 171, 6814-6819.
14. Diefenbach, A., Jensen, E.R., Jamieson, A.M., and Raulet, D.H. (2001). Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity. Nature 413, 165-171. doi: 10.1038/35093109.
15. Dunn, G.P., Bruce, A.T., Ikeda, H., Old, L.J., and Schreiber, R.D. (2002). Cancer immunoediting: from immunosurveillance to tumor escape. Nat Immunol 3, 991-998. doi: 10.1038/ni1102-991.
16. Dunn, G.P., Koebel, C.M., and Schreiber, R.D. (2006). Interferons, immunity and cancer immunoediting. Nat Rev Immunol 6, 836-848. doi: 10.1038/nri1961.
17. Dunn, G.P., Old, L.J., and Schreiber, R.D. (2004a). The immunobiology of cancer immunosurveillance and immunoediting. Immunity 21,137-148. doi: 10.1016/j.immuni.2004.07.017.
18. Dunn, G.P., Old, L.J., and Schreiber, R.D. (2004b). The three Es of cancer immunoediting. Annu Rev Immunol 22, 329-360. doi: 10.1146/annurev.immunol.22.012703.104803.
19. Evnouchidou, I., Birtley, J., Seregin, S., Papakyriakou, A., Zervoudi, E., Samiotaki, M., Stratikos, E. (2012). A common single nucleotide polymorphism in endoplasmic reticulum aminopeptidase 2 induces a specificity switch that leads to altered antigen processing. J Immunol 189, 2383-2392. doi: jimmunol.1200918 [pii] 10.4049/jimmunol.1200918.
20. Evnouchidou, I., Kamal, R.P., Seregin, S.S., Goto, Y., Tsujimoto, M., Hattori, A., Stratikos, E. (2011). Coding single nucleotide polymorphisms of endoplasmic reticulum aminopeptidase 1 can affect antigenic peptide generation in vitro by influencing basic enzymatic properties of the enzyme. J Immunol 186,1909-1913. doi: jimmunol. 1003337 [pii] 10.4049/jimmunol.1003337.
21. Evnouchidou, I., Weimershaus, M., Saveanu, L., and Van Endert, P. (2014). ERAP1-ERAP2 dimerization increases peptide-trimming efficiency. J Immunol 193, 901-908. doi: 10.4049/jimmunol.1302855.
22. Fruci, D., Ferracuti, S., Limongi, M.Z., Cunsolo, V., Giorda, E., Fraioli, R., Giacomini, P. (2006). Expression of endoplasmic reticulum aminopeptidases in EBV-B cell lines from healthy donors and in leukemia/lymphoma, carcinoma, and melanoma cell lines. J Immunol 176, 4869-4879.
23. Fruci, D., Giacomini, P., Nicotra, M.R., Forloni, M., Fraioli, R., Saveanu, L., Natali, P.G. (2008). Altered expression of endoplasmic reticulum aminopeptidases ERAP1 and ERAP2 in transformed non-lymphoid human tissues. J Cell Physiol 216, 742-749.
24. Garcia-Medel, N., Sanz-Bravo, A., Alvarez-Navarro, C., Gomez-Molina, P., Barnea, E., Marcilla, M., Lopez De Castro, J.A. (2014). Peptide handling by HLAB27 subtypes influences their biological behavior, association with ankylosing spondylitis and susceptibility to ERAP1. Mol Cell Proteomics. doi: 10.1074/mcp. M114.039214.
25. Garcia-Medel, N., Sanz-Bravo, A., Van Nguyen, D., Galocha, B., Gomez-Molina, P., Martin-Esteban, A., Lopez De Castro, J.A. (2012). Functional interaction of the ankylosing spondylitis associated endoplasmic reticulum aminopeptidase 1 polymorphism and HLA-B27 in vivo. Mol Cell Proteomics. doi: M112.019588 [pii] 10.1074/mcp. M112.019588.
26. Georgiadou, D., and Stratikos, E. (2009). Cellular mechanisms that edit the immunopeptidome. Current Proteomics 6,13-24.
27. Goto, Y., Hattori, A., Ishii, Y., and Tsujimoto, M. (2006). Reduced activity of the hypertension-associated Lys528Arg mutant of human adipocyte-derived leucine aminopeptidase (A-LAP)/ER-aminopeptidase-1. FEBS Lett 580, 1833-1838.
28. Goto, Y., Ogawa, K., Hattori, A., and Tsujimoto, M. (2011). Secretion of endoplasmic reticulum aminopeptidase 1 is involved in the activation of macrophages induced by lipopolysaccharide and interferon-gamma. J Biol Chem 286, 21906-21914. doi: M111.239111 [pii] 10.1074/jbc. M111.239111.
29. Goto, Y., Ogawa, K., Nakamura, T.J., Hattori, A., and Tsujimoto, M. (2014). TLRmediated secretion of endoplasmic reticulum aminopeptidase 1 from macrophages. J Immunol 192, 4443-4452. doi: 10.4049/jimmunol.1300935.
30. Guerini, F.R., Cagliani, R., Forni, D., Agliardi, C., Caputo, D., Cassinotti, A., Sironi, M. (2012). A functional variant in ERAP1 predisposes to multiple sclerosis. PLoSOne 7, e29931. doi: 10.1371/journal.pone.0029931.
31. Hammer, G.E., Gonzalez, F., Champsaur, M., Cado, D., and Shastri, N. (2006). The aminopeptidase ERAAP shapes the peptide repertoire displayed by major histocompatibility complex class I molecules. Nat Immunol 7,103-112.
32. Hammer, G.E., Gonzalez, F., James, E., Nolla, H., and Shastri, N. (2007). In the absence of aminopeptidase ERAAP, MHC class I molecules present many unstable and highly immunogenic peptides. Nat Immunol 8,101-108.
33. Hasim, A., Abudula, M., Aimiduo, R., Ma, J.Q., Jiao, Z., Akula, G., Abudula, A. (2012). Post-transcriptional and epigenetic regulation of antigen processing machinery (APM) components and HLA-I in cervical cancers from Uighur women. PLoS One 7, e44952. doi: 10.1371/journal.pone.0044952.
34. Hasim, A., Qing, S., Wu, X.C., Ge, L., and Abudula, A. (2010). [Association of expression of antigen processing machinery components with HLA-I in cervical lesions]. Zhonghua Bing LiXue Za Zhi 39, 703-704.
35. Hill, L.D., Hilliard, D.D., York, T.P., Srinivas, S., Kusanovic, J.P., Gomez, R., Strauss, J.F., 3rd (2011). Fetal ERAP2 variation is associated with preeclampsia in African Americans in a case-control study. BMC Med Genet 12, 64. doi: 1471-2350-12-64 [pii] 10.1186/1471-2350-12-64.
36. Hulpke, S., and Tampe, R. (2013). The MHC I loading complex: a multitasking machinery in adaptive immunity. Trends Biochem Sci 38, 412-420. doi: 10.1016/j.tibs.2013.06.003.
37. International Genetics of Ankylosing Spondylitis, C., Cortes, A., Hadler, J., Pointon, J.P., Robinson, P.C., Karaderi, T.,. Brown, M.A. (2013). Identification of multiple risk variants for ankylosing spondylitis through high-density genotyping of immune-related loci. Nat Genet 45, 730-738. doi: 10.1038/ng.2667.
38. James, E., Bailey, I., Sugiyarto, G., and Elliott, T. (2013). Induction of Protective Antitumor Immunity through Attenuation of ERAAP Function. J Immunol 190, 5839-5846. doi: 10.4049/jimmunol.1300220 jimmunol.1300220 [pii].
39. Johnson, M.P., Roten, L.T., Dyer, T.D., East, C.E., Forsmo, S., Blangero, J.,. Moses, E.K. (2009). The ERAP2 gene is associated w i th preeclampsia in Australian and Norwegian populations. Hum Genet 126, 655-666.
40. Kamphausen, E., Kellert, C., Abbas, T., Akkad, N., Tenzer, S., Pawelec, G., Seliger, B. (2010). Distinct molecular mechanisms leading to deficient expression of ER-residentaminopeptidases in melanoma. Cancer Immunol Immunother 59, 1273-1284. doi: 10.1007/s00262-010-0856-7.
41. Karlhofer, F.M., Ribaudo, R.K., and Yokoyama, W.M. (1992). MHC class I alloantigen specificity of Ly-49+ IL-2-activated natural killer cells. Nature 358, 66-70. doi: 10.1038/358066a0.
42. Kim, S., Sunwoo, J.B., Yang, L., Choi, T., Song, Y.J., French, A.R., Yokoyama, W.M. (2008). HLA alleles determine differences in human natural killer cell responsiveness and potency. Proc Natl Acad Sci USA 105, 3053-3058. doi: 10.1073/pnas.0712229105.
43. Kirino, Y., Bertsias, G., Ishigatsubo, Y., Mizuki, N., Tugal-Tutkun, I., Seyahi, E., Kastner, D.L. (2013). Genome-wide association analysis identifies new susceptibility loci for Behcets disease and epistasis between HLA-B*51 and ERAP1. Nat Genet 45, 202-207. doi: 10.1038/ng.2520 ng.2520 [pii].
44. Kochan, G., Krojer, T., Harvey, D., Fischer, R., Chen, L., Vollmar, M.,. Oppermann, U. (2011). Crystal structures of the endoplasmic reticulum aminopeptidase-1 (ERAP1) reveal the molecular basis for N-terminal peptide trimming. Proc Natl Acad Sci USA 108, 7745-7750. doi: 10.1073/pnas.1101262108 1101262108 [pii].
45. Kuiper, J.J., Van Setten, J., Ripke, S., Van T Slot, R., Mulder, F., Missotten, T.,. Koeleman, B.P. (2014). A genome-wide association study identifies a functional ERAP2 haplotype associated w i th birdshot chorioretinopathy. Hum Mol Genet. doi: 10.1093/hmg/ddu307.
46. Lanier, L.L. (2008). Evolutionary struggles between NK cells and viruses. Nat Rev Immunol 8, 259-268. doi: 10.1038/nri2276.
47. Maksymowych, W.P., Inman, R.D., Gladman, D.D., Reeve, J.P., Pope, A., and Rahman, P. (2009). Association of a specific ERAP1/ARTS1 haplotype w i t h disease susceptibility in ankylosing spondylitis. Arthritis Rheum 60, 1317-1323.
48. Martin-Esteban, A., Gomez-Molina, P., Sanz-Bravo, A., and Lopez De Castro, J.A. (2013). Combined effects of ankylosing spondylitis-associated ERAP1 polymorphisms outside the catalytic and peptide-binding sites on the processing of natural HLA-B27 ligands. J Biol Chem. doi: 10.1074/jbc. M113.529610.
49. Mehta, A.M., Jordanova, E.S., Corver, W.E., Van Wezel, T., Uh, H.W., Kenter, G.G., and Jan Fleuren, G. (2009). Single nucleotide polymorphisms in antigen processing machinery component ERAP1 significantly associate with clinical outcome in cervical carcinoma. Genes Chromosomes Cancer 48, 410-418.
50. Mehta, A.M., Jordanova, E.S., Kenter, G.G., Ferrone, S., and Fleuren, G.J. (2008). Association of antigen processing machinery and HLA class I defects with clinicopathological outcome in cervical carcinoma. Cancer Immunol Immunother 57,197-206.
51. Mehta, A.M., Jordanova, E.S., Van Wezel, T., Uh, H.W., Corver, W.E., Kwappenberg, K.M., Fleuren, G.J. (2007). Genetic variation of antigen processing machinery components and association with cervical carcinoma. Genes Chromosomes Cancer 46, 577-586.
52. Nguyen, T.T., Chang, S.C., Evnouchidou, I., York, I.A., Zikos, C., Rock, K.L., Stern, L.J. (2011). Structural basis for antigenic peptide precursor processing by the endoplasmic reticulum aminopeptidase ERAP1. Nat Struct Mol Biol 18, 604-613. doi: nsmb.2021 [pii] 10.1038/nsmb.2021.
53. Ombrello, M.J., Kirino, Y., De Bakker, P.I., Gul, A., Kastner, D.L., and Remmers, E.F. (2014). Behcet disease-associated MHC class I residues implicate antigen binding and regulation of cell-mediated cytotoxicity. Proc Natl Acad Sci U SA 111, 8867-8872. doi: 10.1073/pnas.1406575111.
54. Orr, M.T., Murphy, W.J., and Lanier, L.L. (2010). Unlicensed natural killer cells dominate the response to cytomegalovirus infection. Nat Immunol 11, 321-327. doi: 10.1038/ni.1849.
55. Rastall, D.P., Aldhamen, Y.A., Seregin, S.S., Godbehere, S., and Amalfitano, A. (2014). ERAP1 functions override the intrinsic selection of specific antigens as immunodominant peptides, thereby altering the potency of antigen-specific cytolytic and effector memory T-cell responses. Int Immunol. doi: 10.1093/intimm/dxu078.
56. Raulet, D.H., Vance, R.E., and Mcmahon, C.W. (2001). Regulation of the natural killer cell receptor repertoire. Annu Rev Immunol 19, 291-330. doi: 10.1146/annurev.immunol.19.1.291.
57. Reeves, E., Colebatch, A., Elliott, T., Edwards, C., and James, E. (2014). Functionally distinct ERAP1 allotype combinations distinguish individuals with Ankylosing Spondylitis. Proc Natl Acad Sci USA.
58. Reeves, E., Edwards, C.J., Elliott, T., and James, E. (2013). Naturally occurring ERAP1 haplotypes encode functionally distinct alleles with fine substrate specificity. J Immunol 191, 35-43. doi: 10.4049/jimmunol.1300598 jimmunol.1300598 [pii].
59. Saveanu, L., Carroll, O., Lindo, V., Del Val, M., Lopez, D., Lepelletier, Y., Van Endert, P.M. (2005). Concerted peptide trimming by human ERAP1 and ERAP2 aminopeptidase complexes in the endoplasmic reticulum. Nat Immunol 6, 689-697.
60. Seregin, S.S., Rastall, D.P., Evnouchidou, I., Aylsworth, C.F., Quiroga, D., Kamal, R.P., Amalfitano, A. (2013). Endoplasmic reticulum aminopeptidase-1 alleles associated with increased risk of ankylosing spondylitis reduce HLA-B27 mediated presentation of multiple antigens. Autoimmunity. doi: 10.3109/08916934.2013.819855.
61. Serwold, T., Gonzalez, F., Kim, J., Jacob, R., and Shastri, N. (2002). ERAAP customizes peptides for MHC class I molecules in the endoplasmic reticulum. Nature 419, 480-483.
62. Smyth, M.J., Dunn, G.P., and Schreiber, R.D. (2006). Cancer immunosurveillance and immunoediting: the roles of immunity in suppressing tumor development and shaping tumor immunogenicity. Adv Immunol 90,1-50. doi:10.1016/S0065-2776(06)90001-7.
63. Stoehr, C.G., Buettner-Herold, M., Kamphausen, E., Bertz, S., Hartmann, A., and Seliger, B. (2013). Comparative expression profiling for human endoplasmic reticulum-residentaminopeptidases 1 and 2 in normal kidney versus distinct renal cell carcinoma subtypes. IntJ Clin Exp Pathol 6,998-1008.
64. Strange, A., Capon, F., Spencer, C.C., Knight, J., Weale, M.E., Allen, M.H., Trembath, R.C. (2010). A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1. Nat Genet 42, 985-990. doi: 10.1038/ng.694 ng.694 [pii].
65. Swann, J.B., and Smyth, M.J. (2007). Immune surveillance of tumors. J Clin Invest 117, 1137-1146. doi: 10.1172/JCI31405.
66. Szczypiorska, M., Sanchez, A., Bartolome, N., Arteta, D., Sanz, J., Brito, E., Mulero, J. (2011). ERAP1 polymorphisms and haplotypes are associated with ankylosing spondylitis susceptibility and functional severity in a Spanish population. Rheumatology (Oxford) 50,1969-1975. doi: 10.1093/rheumatology/ker229.
67. Tanioka, T., Hattori, A., Masuda, S., Nomura, Y., Nakayama, H., Mizutani, S., and Tsujimoto, M. (2003). Human leukocyte-derived arginine aminopeptidase. The third member of the oxytocinase subfamily of aminopeptidases. J Biol Chem 278, 32275-32283.
68. The Australo-Anglo-American Spondyloarthritis, C., The Wellcome Trust Case Control, C., Evans, D.M., Spencer, C.C., Pointon, J.J., Su, Z., Donnelly, P. (2011). Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 disease susceptibility. Nat Genet 43, 761-767. doi: 10.1038/ng.873 ng.873 [pii].
69. Tsui, F.W., Haroon, N., Reveille, J.D., Rahman, P., Chiu, B., Tsui, H.W., and Inman, R.D. (2010). Association of an ERAP1 ERAP2 haplotype with familial ankylosing spondylitis. Ann Rheum Dis 69, 733-736. doi: ard.2008.103804 [pii] 10.1136/ard.2008.103804.
70. Vanhille, D.L., Hill, L.D., Hilliard, D.D., Lee, E.D., Teves, M.E., Srinivas, S., Strauss, J.F., 3rd (2013). A Novel Haplotype Structure in a Chilean Population: Implications for ERAP2 Protein Expression and Preeclampsia Risk. Mol Genet Genomic Med 1, 98-107. doi: 10.1002/mgg3.13.
71. Weimershaus, M., Evnouchidou, I., Saveanu, L., and Van Endert, P. (2013). Peptidases trimming MHC class I ligands. Curr Opin Immunol 25, 90-96. doi: 10.1016/j.coi.2012.10.001.
72. Yamamoto, N., Nakayama, J., Yamakawa-Kobayashi, K., Hamaguchi, H., Miyazaki, R., and Arinami, T. (2002). Identification of 33 polymorphisms in the adipocyte-derived leucine aminopeptidase (ALAP) gene and possible association with hypertension. Hum Mutat 19, 251-257.
73. Yan, J., Parekh, V.V., Mendez-Fernandez, Y., Olivares-Villagomez, D., Dragovic, S., Hill, T., Van Kaer, L. (2006). In vivo role of ER-associated peptidase activity in tailoring peptides for presentation by MHC class Ia and class Ib molecules. J Exp Med 203, 647-659.
74. York, I.A., Brehm, M.A., Zendzian, S., Towne, C.F., and Rock, K.L. (2006). Endoplasmic reticulum aminopeptidase 1 (ERAP1) trims MHC class Ipresented peptides in vivo and plays an important role in immunodominance. Proc Natl AcadSci USA 103, 9202-9207.
75. York, I.A., Chang, S.C., Saric, T., Keys, J.A., Favreau, J.M., Goldberg, A.L., and Rock, K.L. (2002). The ER aminopeptidase ERAP1 enhances or limits antigen presentation by trimming epitopes to 8-9 residues. Nat Immunol 3,1177-1184.
76. Zervoudi, E., Papakyriakou, A., Georgiadou, D., Evnouchidou, I., Gajda, A., Poreba, M., Stratikos, E. (2011). Probing the S1 specificity pocket of the aminopeptidases that generate antigenic peptides. Biochem J 435, 411-420. doi: BJ20102049 [pii] 10.1042/BJ20102049.
77. Zervoudi, E., Saridakis, E., Birtley, J.R., Seregin, S.S., Reeves, E., Kokkala, P., Stratikos, E. (2013). Rationally designed inhibitor targeting antigentrimming aminopeptidases enhances antigen presentation and cytotoxic T-cell responses. Proc Natl AcadSci USA 110,19890-19895. doi: 10.1073/pnas.1309781110.